News

Find News

Filter articles

Applied Filters

Showing 901 to 910 of 919 results

OFT accuses GSK of market abuse over pay-for-delay deals

UK19-04-2013

The UK Office of Fair Trading has accused GlaxoSmithKline of abusing its market dominance and infringing UK competition law by paying rivals to delay releasing generic versions of its anti-depressant Seroxat.

Novartis sues three over generic Zometa

US17-04-2013

Swiss pharmaceutical firm Novartis has filed a lawsuit against Accord Healthcare, Fresenius Kabi and Hikma Farmaceutica for applying to market generic versions of its cancer drug Zometa.

USPTO names Patents for Humanity winners

US12-04-2013

The US Patent and Trademark Office has announced the winners of its Patents for Humanity competition, which recognises patent owners and licensees addressing global health and development challenges.

Merck fails to ban Indian diabetes generics

India08-04-2013

Merck is the latest multinational pharma company to suffer a setback in India, after failing to win an injunction against generic versions of two anti-diabetes drugs.

India's Novartis ruling: the implications for patent owners

India03-04-2013

India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty.

AstraZeneca settles Crestor patent dispute

US27-03-2013

UK pharmaceutical company AstraZeneca has reached a settlement with Actavis and Egis Pharmaceuticals that delays the release of generic versions of its cholesterol treatment Crestor.

Bayer sues Glenmark over generic Finacea

US15-03-2013

Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of rosacea treatment Finacea.

Mylan signs generic truce with Shionogi and Andrx

Japan, US15-03-2013

Generic drug maker Mylan has struck a deal with pharma companies Shionogi and Andrx to resolve a patent dispute over their diabetes drug Fortamet.

Janssen sues Hetero over generic HIV treatment

14-03-2013

Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.

ViiV Healthcare joins patent pool for cheaper AIDS drugs

28-02-2013

ViiV Healthcare, a public health joint venture between GlaxoSmithKline, Shionogi and Pfizer, has signed up to the Medicines Patent Pool (MPP) to provide greater access to affordable AIDS treatments in developing countries.

Showing 901 to 910 of 919 results

LSIPR